China's Generic Drugmakers Challenge India

China is coming from behind and challenging India in an industry it has traditionally dominated

During the first week of August, drug multinational (MNC) Novartis suffered a setback in India when it lost a legal challenge to the country's patent law.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.